Antion Biosciences announces development of safety-enhanced
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases...
Stay updated with breaking news from Des Aulx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases...
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseasesGENEVA, May 22, 2024 (GLOBE NEWSWIRE) -- Antion Biosciences (Antion), a Geneva-based cell and gene therapy company
GENEVA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, is ple...
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – July 13, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's health, today
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 8, 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical...